Foster City, CA, United States of America

Richard P Polniaszek

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Gilead Sciences, Inc., Bristol-Myers Squibb Compnay. Active years: 1996-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard P Polniaszek. Retrieved from https://idiyas.com/inventor/richard-p-polniaszek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 64(Granted Patents)

Location History:

South Brunswick, NJ (US) (1996)
Dayton, NJ (US) (1999 - 2003)
Foster City, CA (US) (2003 - 2013)
Redwood City, CA (US) (2006 - 2014)
Half Moon Bay, CA (US) (2013 - 2016)
Menlo Park, CA (US) (2016 - 2019)

Company Filing History:

14 out of 946

Gilead Sciences, Inc.

patents

7 out of 3,742

Bristol-Myers Squibb Compnay

patents

Years Active: 1996-2019

Loading Chart...

Areas of Expertise:

HIV Inhibitors

Pharmaceutical Agents

Antiviral Compounds

Biphenyl Isoxazole Sulfonamides

Protease Inhibitors

Chemical Processes

Intermediates

Salts

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10196419 - Processes and intermediates for preparing anti-HIV agents (2019-02-05),

2. 9783568 - Salts of HIV inhibitor compounds (2017-10-10),

3. 9783567 - Processes and intermediates for preparing anti-HIV agents (2017-10-10),

4. 9428473 - Methods and intermediates for preparing pharmaceutical agents (2016-08-30),

5. 9381206 - Salts of HIV inhibitor compounds (2016-07-05),

6. 9296779 - Processes and intermediates for preparing anti-HIV agents (2016-03-29),

7. 9115100 - Methods and intermediates for preparing pharmaceutical agents (2015-08-25),

8. 8987437 - Processes and intermediates for preparing anti-HIV Agents (2015-03-24),

9. 8951986 - Salts of HIV inhibitor compounds (2015-02-10),

10. 8853210 - Methods and intermediates for preparing pharmaceutical agents (2014-10-07),

11. 8658617 - Salts of HIV inhibitor compounds (2014-02-25),

12. 8497396 - Methods and intermediates for preparing pharmaceutical agents (2013-07-30),

13. 8431745 - Process for preparation of HIV protease inhibitors (2013-04-30),

14. 8173623 - Process for preparation of HIV protease inhibitors (2012-05-08),

15. 7550619 - Intermediates in the preparation of the antiviral agent [1S-(1α, 3α, 4β)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxmethyl)-2-methylenecyclopentyl]-6H-purin-6-one (2009-06-23),

Title: Richard P. Polniaszek - Innovator in Anti-HIV Research

Introduction

Richard P. Polniaszek is a prominent inventor based in Foster City, CA, known for his innovative contributions to the pharmaceutical field, particularly in the development of anti-HIV agents. With an impressive portfolio of 21 patents, Polniaszek has made significant strides in synthetic processes that aid in the fight against HIV.

Latest Patents

Among his latest patents, Richard has focused on "Processes and Intermediates for Preparing Anti-HIV Agents." This invention provides critical synthetic processes and intermediates that are essential for creating compounds with effective anti-HIV properties. His research continues to pave the way for advancements in HIV treatments and underscores the importance of innovation in combating viral infections.

Career Highlights

Throughout his career, Richard has worked with leading pharmaceutical companies, including Gilead Sciences, Inc. and Bristol-Myers Squibb Company. His roles in these organizations have allowed him to be at the forefront of research and development, contributing to life-saving medications and therapeutic solutions.

Collaborations

Richard's work has also involved collaboration with notable colleagues such as Benjamin R. Graetz and Kenneth M. Kent. These partnerships have fostered a collaborative environment that enhances the creative processes behind his inventions and the development of novel therapeutic agents.

Conclusion

Richard P. Polniaszek exemplifies the role of inventors in the medical field, demonstrating how innovation plays a critical part in addressing global health challenges. His dedication to researching and developing anti-HIV agents through synthetic processes showcases the impact of his work on public health and underscores the importance of continued innovation in healthcare.

Profile summary based on public USPTO records.